Cubist Systematic Strategies’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Cubist Systematic Strategies’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-255,371	Closed	-$2.67M	–	4546
2023 Q1	$2.67M	Sell	255,371 -293,868	-54%	-$3.04M	0.02%	1435
2022 Q4	$5.61M	Sell	549,239 -5,407	-1%	-$54.9K	0.03%	914
2022 Q3	$5.57M	Sell	554,646 -439	-0.1%	-$4.39K	0.03%	974
2022 Q2	$5.52M	Buy	555,085 +14,918	+3%	+$148K	0.03%	901
2022 Q1	$5.34M	Buy	+540,167	New	+$5.33M	0.05%	680

Other funds holding BIOS

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Quarry LP New York $1.2B AUM 47.63% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Cubist Systematic Strategies's BIOS Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q2 2023, closing a stake of 255,371 shares — an estimated $2.67M sold.

Cubist Systematic Strategies first reported a position in BIOS in Q1 2022 and held it in 5 quarters. The position peaked at $5.61M in Q4 2022. 32 funds tracked by Wall St. Rank hold BIOS as of Q2 2023.

Cubist Systematic Strategies reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 255,371 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q2 2023, an estimated $2.67M.
Cubist Systematic Strategies first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 5 quarters.
Cubist Systematic Strategies's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $5.61M in Q4 2022.
32 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.